High dietary salt intake exacerbates Helicobacter pylori-induced gastric carcinogenesis

Infection and Immunity

Volumn 81, Issue 6, 2013, Pages 2258-2267

  Gaddy, Jennifer A ^a   Radin, Jana N ^a   Loh, John T ^a   Zhang, Feng ^a   Kay Washington, M ^a   Peek, Richard M ^a   Scott Algood, Holly M ^a,b   Cover, Timothy L ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPCIDIN; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; INTERLEUKIN 1BETA;

ACHLORHYDRIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CULTURE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPLASIA; GASTRITIS; HELICOBACTER PYLORI; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SALT INTAKE; STOMACH ADENOCARCINOMA; STOMACH CARCINOGENESIS; STOMACH MUSCLE; STOMACH PARIETAL CELL; STOMACH PH; TUMOR INVASION; UPREGULATION;

EID: 84877803917     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01271-12     Document Type: Article

References (56)

1. Cover T, Blaser M. 2009. Helicobacter pylori in health and disease. Gastroenterology 136:1863-1873.
2. Atherton J, Blaser M. 2009. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J. Clin. Invest. 119:2475-2487.
3. Algood H, Cover T. 2006. Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin. Microbiol. Rev. 19:597-613.
4. Wroblewski L, Peek R, Jr, Wilson K. 2010. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin. Microbiol. Rev. 23:713-739.
5. Fox J, Wang T. 2007. Inflammation, atrophy, and gastric cancer. J. Clin. Invest. 117:60-69.
6. IARC. 1994. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr. Eval. Carcinog. Risks Hum. 61:1-241.
7. Peek R, Jr, Blaser M. 2002. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2:28-37.
8. Blaser M, Berg D. 2001. Helicobacter pylori genetic diversity and risk of human disease. J. Clin. Invest. 107:767-773.
9. Suerbaum S, Josenhans C. 2007. Helicobacter pylori evolution and phenotypic diversification in a changing host. Nat. Rev. Microbiol. 5:441-452.
10. Tegtmeyer N, Wessler S, Backert S. 2011. Role of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis. FEBS J. 278:1190-1202.
11. Fischer W. 2011. Assembly and molecular mode of action of the Helicobacter pylori Cag type IV secretion apparatus. FEBS J. 278:1203-1212.
12. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R. 2000. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287:1497-1500.
13. Bourzac K, Guillemin K. 2005. Helicobacter pylori-host cell interactions mediated by type IV secretion. Cell Microbiol. 7:911-919.
14. Tan S, Noto J, Romero-Gallo J, Peek R, Jr, Amieva M. 2011. Helicobacter pylori perturbs iron trafficking in the epithelium to grow on the cell surface. PLoS Pathog. 7:e1002050. doi:10.1371/journal.ppat.1002050.
15. Hatakeyama M. 2011. Anthropological and clinical implications for the structural diversity of the Helicobacter pylori CagA oncoprotein. Cancer Sci. 102:36-43.
16. Hatakeyama M. 2004. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat. Rev. Cancer 4:688-694.
17. Merrell DS, Thompson LJ, Kim CC, Mitchell H, Tompkins LS, Lee A, Falkow S. 2003. Growth phase dependent response of Helicobacter pylori to iron starvation. Infect. Immun. 71:6510-6525.
18. Noto J, Gaddy J, Lee J, Piazuelo M, Friedman D, Colvin D, Romero-Gallo J, Suarez G, Loh J, Slaughter J, Tan S, Morgan D, Wilson K, Bravo L, Correa P, Cover T, Amieva M, Peek R, Jr. 2013. Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. J. Clin. Invest. 123:479-492.
19. Merrell D, Goodrich M, Otto G, Tompkins L, Falkow S. 2003. pHregulated gene expression of the gastric pathogen Helicobacter pylori. Infect. Immun. 71:3529-3539.
20. Loh J, Torres V, Cover T. 2007. Regulation of Helicobacter pylori cagA expression in response to salt. Cancer Res. 67:4709-4715.
21. Pich O, Carpenter B, Gilbreath J, Merrell D. 2012. Detailed analysis of Helicobacter pylori Fur-regulated promoters reveals a Fur box core sequence and novel Fur-regulated genes. Mol. Microbiol. 84:921-941.
22. Loh J, Friedman D, Piazuelo M, Bravo L, Wilson K, Peek R, Jr, Correa P, Cover T. 2012. Analysis of Helicobacter pylori cagA promoter elements required for salt-induced upregulation of CagA expression. Infect. Immun. 80:3094-3106.
23. Duncan S, Valk P, Shaffer C, Bordenstein S, Cover T. 2012. J-Western forms of Helicobacter pylori cagA constitute a distinct phylogenetic group with a widespread geographic distribution. J. Bacteriol. 194:1593-1604.
24. Loh J, Shaffer C, Piazuelo M, Bravo L, McClain M, Correa P, Cover T. 2011. Analysis of cagA in Helicobacter pylori strains from Colombian populations with contrasting gastric cancer risk reveals a biomarker for disease severity. Cancer Epidemiol. Biomarkers Prev. 20:2237-2249.
25. Lee S, Kang D, Shim K, Choe J, Hong W, Choi H. 2003. Effect of diet and Helicobacter pylori infection to the risk of early gastric cancer. J. Epidemiol. 13:162-168.
26. Tsugane S, Sasazuki S. 2007. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 10:75-83.
27. Wang X, Terry P, Yan H. 2009. Review of salt consumption and stomach cancer risk: epidemiological and biological evidence. World J. Gastroenterol. 15:2204-2213.
28. D'Elia L, Rossi G, Ippolito R, Cappuccio F, Strazzullo P. 2012. Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin. Nutr. 31:489-498.
29. Brenner H, Rothenbacher D, Arndt V. 2009. Epidemiology of stomach cancer. Methods Mol. Biol. 472:467-477.
30. Krejs G. 2010. Gastric cancer: epidemiology and risk factors. Dig. Dis. Sci. 28:600-603.
31. Toyoda T, Tsukamoto T, Hirano N, Mizoshita T, Kato S, Takasu S, Ban H, Tatematsu M. 2008. Synergistic upregulation of inducible nitric oxide synthase and cyclooxygenase-2 in gastric mucosa of Mongolian gerbils by a high-salt diet and Helicobacter pylori infection. Histol. Histopathol. 23: 593-599.
32. Gamboa-Dominguez A, Ubbelohde T, Saqui-Salces M, Romano-Mazzoti L, Cervantes M, Domínguez-Fonseca C, de la Luz Estreber M, Ruíz-Palacios GM. 2007. Salt and stress synergize H. pylori-induced gastric lesions, cell proliferation, and p21 expression in Mongolian gerbils. Dig. Dis. Sci. 52:1517-1526.
33. Kato S, Tsukamoto T, Mizoshita T, Tanaka H, Kumagai T, Ota H, Katsuyama T, Asaka M, Tatematsu M. 2006. High salt diets dosedependently promote gastric chemical carcinogenesis in Helicobacter pylori-infected Mongolian gerbils associated with a shift in mucin production from glandular to surface mucous cells. Int. J. Cancer 119:1558-1566.
34. Bergin I, Sheppard B, Fox J. 2003. Helicobacter pylori infection and high dietary salt independently induce atrophic gastritis and intestinal metaplasia in commercially available outbred Mongolian gerbils. Dig. Dis. Sci. 48:475-485.
35. Fox J, Dangler C, Taylor N, King A, Koh T, Wang T. 1999. High-salt diet induces gastric epithelial hyperplasia and parietal cell loss, and enhances Helicobacter pylori colonization in C57BL/6 mice. Cancer Res. 59:4823-4828.
36. Fox J, Rogers A, Ihrig M, Taylor N, Whary M, Dockray G, Varro A, Wang T. 2003. Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res. 63:942-950.
37. Rogers A, Taylor N, Whary M, Stefanich E, Wang T, Fox J. 2005. Helicobacter pylori but not high salt induces gastric intraepithelial neoplasia in B6129 mice. Cancer Res. 65:10709-10715.
38. Crabtree J, Ferrero R, Kusters J. 2002. The mouse colonizing Helicobacter pylori strain SS1 may lack a functional cag pathogenicity island. Helicobacter 7:139-140. (Author's reply, 7:140-141.)
39. Philpott D, Belaid D, Troubadour P, Thiberge J, Tankovic J, Labigne A, Ferrero R. 2002. Reduced activation of inflammatory responses in host cells by mouse-adapted Helicobacter pylori isolates. Cell Microbiol. 4:285-296.
40. Franco A, Israel D, Washington M, Krishna U, Fox J, Rogers A, Neish A, Collier-Hyams L, Perez-Perez G, Hatakeyama M, Whitehead R, Gaus K, O'Brien D, Romero-Gallo J, Peek R, Jr. 2005. Activation of betacatenin by carcinogenic Helicobacter pylori. Proc. Natl. Acad. Sci. U.S.A. 102:10646-10651.
41. Franco A, Johnston E, Krishna U, Yamaoka Y, Israel D, Nagy T, Wroblewski L, Piazuelo MB, Correa P, Peek RM Jr. 2008. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res. 68:379-387.
42. Tummuru M, Cover T, Blaser M. 1994. Mutation of the cytotoxinassociated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect. Immun. 62:2609-2613.
43. Romero-Gallo J, Harris E, Krishna U, Washington M, Perez-Perez G, Peek R, Jr. 2008. Effect of Helicobacter pylori eradication on gastric carcinogenesis. Lab. Invest. 88:328-336.
44. Rieder G, Merchant J, Haas R. 2005. Helicobacter pylori cag-type IV secretion system facilitates corpus colonization to induce precancerous conditions in Mongolian gerbils. Gastroenterology 128:1229-1242.
45. Correa P. 1992. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 52:6735-6740.
46. El-Omar E. 2001. The importance of interleukin 1 beta in Helicobacter pylori associated disease. Gut 48:743-747.
47. Schwarz P, Kubler J, Strnad P, Muller K, Barth T, Gerloff A, Feick P, Peyssonnaux C, Vaulont S, Adler G, Kulaksiz H. 2012. Hepcidin is localised in gastric parietal cells, regulates acid secretion and is induced by Helicobacter pylori infection. Gut 61:193-201.
48. Schubert M. 2011. Gastric secretion. Curr. Opin. Gastroenterol. 27:536-542.
49. Scott D, Marcus E, Wen Y, Oh J, Sachs G. 2007. Gene expression in vivo shows that Helicobacter pylori colonizes an acidic niche on the gastric surface. Proc. Natl. Acad. Sci. U.S.A. 104:7235-7240.
50. Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M, Matsui A, Higashi H, Musashi M, Iwabuchi K, Suzuki M, Yamada G, Azuma T, Hatakeyama M. 2008. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc. Natl. Acad. Sci. U.S.A. 105:1003-1008.
51. Blaser M, Perez-Perez G, Kleanthous H, Cover T, Peek R, Chyou P, Stemmermann G, Nomura A. 1995. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55:2111-2115.
52. Krieg L, Milstein O, Krebs P, Xia Y, Beutler B, Du X. 2011. Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes irondeficiency anemia in mice. Blood 118:6418-6425.
53. Miret S, Simpson R, McKie A. 2003. Physiology and molecular biology of dietary iron absorption. Annu. Rev. Nutr. 23:283-301.
54. Annibale B, Capurso G, Delle Fave G. 2003. The stomach and iron deficiency anaemia: a forgotten link. Dig. Liver Dis. 35:288-295.
55. Datta De D, Bhattacharjya S, Maitra M, Datta A, Choudhury A, Dhali G, Roychoudhury S. 2011. IL1B induced Smad 7 negatively regulates gastrin expression. PLoS One 6:e14775. doi:10.1371/journal .pone.0014775.
56. Smolka A, Backert S. 2012. How Helicobacter pylori infection controls gastric acid secretion. J. Gastroenterol. 47:609-618.